Roche
US stocks mixed as Nvidia, Iran tensions weigh; SMI edges lower
Dow ekes out gains while S&P 500 and Nasdaq 100 retreat; Nvidia faces scrutiny ahead of earnings. SMI slips 0.26% as ABB, Roche weigh.
Swiss stocks slip as pharma giants weigh; Nestlé rises, biotech drags
SMI falls 0.25% to 14,423 as Roche and Novartis decline; Nestlé gains 0.5%. Biotech sector under pressure amid broader market caution ahead of key U.S. events.
Swiss market falls as Roche, Novartis weigh; Nestlé, Holcim rise
SMI slips 0.15% as pharma majors drag; Nestlé gains 0.5% while biotech stocks retreat. Brent oil drops 1.5% to $92.94 amid geopolitical jitters.
Swiss market opens lower as pharma stocks weigh; gold hits 3-month high
SMI falls 0.22% in pre-market as Roche and Novartis drag; DAX seen little changed. Brent oil dips 1.5% to $92.94/barrel; WTI at $85.61. Gold climbs 0.75% to $4,637/oz.
Roche issues CHF 410 million bond due 2036 with 1.095% coupon
The Swiss healthcare giant places a new 10-year Swiss franc bond at par, offering an annual yield of 1.095%. The issue is rated Aa2 by Moody's and trades from a minimum of 1,000 nominal units.
SMI rebounds to close higher on strong pharma, cyclical stocks
Swiss benchmark rises 0.62% after midday reversal led by Roche and Novartis; broader gains in materials and industrials offset early losses. Brent crude remains above $94 a barrel amid Middle East tensions.
Swiss stocks edge higher as Roche, Novartis offset losses; Logitech slides
SMI gains 0.1% as healthcare giants support index; Logitech drops 1.3% after JP Morgan downgrade. Oil holds near $92, gold dips as yields fall.
Swiss equities edge higher as Roche, Novartis offset Logitech decline
SMI advances 0.1% on pharma strength; Centiel surges 18% after analyst upgrade. Oil holds near $92/bbl as geopolitical risks persist.
Swiss SMI rebounds into positive territory after midday losses
The SMI turned positive by 0.15% after trading lower all day, with Roche and Novartis narrowing declines. Brent crude held above $93 a barrel amid Middle East tensions.
Swiss stocks rise as 19 of 20 SMI components gain; Roche leads, Aryzta slumps
The SMI advanced 0.12-0.16% with Roche up 0.52% as 19 of 20 index members gained. Aryzta tumbled over 6% after UBS downgraded it to sell amid broader market strength.
Swiss SMI posts second straight weekly loss as pharma, Partners Group slide
The Swiss Market Index falls 0.34% to 14,319.29 as Roche, Novartis and Partners Group weigh on blue chips. Brent crude holds above $93 a barrel amid Middle East tensions.
Genentech to invest $750 million in U.S. manufacturing expansion
Roche’s biotech unit plans new Hillsboro, Oregon facility as part of a $750 million investment to expand U.S. production capacity.
Swiss Market Index dips 0.1% as Logitech, Richemont, Swiss Re fall
Heavyweights Roche and Lonza advance while Givaudan leads gains; Centiel surges 6.4% on strong half-year results and U.S. contract. Walmart drags U.S. markets lower after weak quarterly sales.
Swiss stocks rise; Geberit surges 7.4% on strong half-year results
Swiss market leads Europe as SMI gains 0.5% to 14,387; Roche and Novartis advance on pharma optimism, while insurance stocks lag amid bond-market pressures.
M&G appoints Daiichi Life executive as non-executive director
Hitoshi Yamaguchi joins M&G’s board as part of a strategic partnership with Daiichi Life Group. The appointment strengthens ties between the insurers and takes effect in September 2026.
US stocks mixed pre-market; Moderna surges 100% on cancer therapy data
Moderna jumps 100% in premarket trading after data showed its personalized mRNA cancer vaccine combined with Merck’s Keytruda cut melanoma recurrence. SMI rises 0.36% as Lowe’s cuts guidance, Estee Lauder gains.
Genentech completes $2 bln North Carolina biomanufacturing facility
Structural framework finished for Genentech's first East Coast plant, part of a $50 bln Roche commitment to U.S. biotech infrastructure. Facility to employ 2,000+ once operational.
Swiss SMI gains 0.5% as Geberit, Roche lead; Alcon, insurers lag
Defensive heavyweights and strong earnings from Geberit drove the Swiss benchmark higher, while Alcon and insurance stocks declined. Second-tier movers included Implenia, Skan and LLB on results.
Swiss stocks edge up as Roche, Novartis lead; ABB, Amrize weigh
The SMI rose 0.13% to 14,321 points, with healthcare heavyweights Roche and Novartis offsetting losses in ABB and Amrize. Global bond yields surged to multi-year highs, unsettling investors.
US stocks rise as Moderna surges 150% on cancer vaccine data
Moderna’s mRNA cancer vaccine trial results drive a 150% jump in its shares, lifting the S&P 500 and Swiss pharma stocks. US net interest payments hit a record 3.3% of GDP.
US stocks rise as Moderna surges; US net interest costs hit record high
Moderna’s 118% rally lifts biotech and Swiss pharma; Dow, S&P 500 and Nasdaq 100 advance. US net interest payments climb to 3.3% of GDP, highest on record.
Global stocks slip as yields surge; Swiss market edges up on pharma gains
Nasdaq leads losses as U.S. 30-year yields hit 19-year high. SMI ekes out gains on Roche, Novartis gains; ABB falls. Brent crude near $91, gold dips.
Swiss stocks rise as Roche, Novartis offset losses; Nasdaq falls sharply
SMI gains 0.13% with healthcare giants leading gains, while U.S. tech selloff drags Nasdaq down 1.49%. ABB and cyclicals decline as bond yields climb to multi-year highs.
Swiss stocks slip as global markets waver; Roche, Novartis advance
Swiss Market Index fell 0.13% as U.S. futures declined on rising bond yields and Middle East tensions. Roche and Novartis led Swiss gains, while cyclicals like ABB lagged. U.S. tech and AI-linked stocks retreated.